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Abstract
Background: The paradigm of translational medicine that underpins frameworks such as the
Cooksey report on the funding of health research does not adequately reflect the complex reality
of the public health environment. We therefore outline a translational framework for public health
research.
Discussion: Our framework redefines the objective of translation from that of institutionalising
effective interventions to that of improving population health by influencing both individual and
collective determinants of health. It incorporates epidemiological perspectives with those of the
social sciences, recognising that many types of research may contribute to the shaping of policy,
practice and future research. It also identifies a pivotal role for evidence synthesis and the
importance of non-linear and intersectoral interfaces with the public realm.
Summary: We propose a research agenda to advance the field and argue that resources for
'applied' or 'translational' public health research should be deployed across the framework, not
reserved for 'dissemination' or 'implementation'.
Background
The translation of health research is increasingly regarded
as important – not only in the UK but also across Europe
and North America – in order to maximise the population
health benefits of investment in research and health care
delivery [1]. However, 'translation' and 'translational
research' mean different things to different people. The
Canadian Institutes of Health Research (CIHR) define
'knowledge translation' in terms of exchange, synthesis,
dialogue and interaction between researchers and users –
a 'radically different' model from the unidirectional flow
of knowledge sometimes implied by terms such as 'dis-
semination' or 'knowledge transfer' [2]. It is also recog-
nised that many contemporary health challenges require
a more fundamental and wide-ranging societal response
than those that can be offered through established sys-
tems of delivering health care [3]. This is the domain of
public health, the nature and scope of which is not univer-
sally understood [4].
In this paper, we therefore propose a translational frame-
work for public health research. Although our framework
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uation in the UK, the issues we address are general and
equally applicable to an international audience.
Translational research and clinical medicine
The Cooksey report, whose recommendations were
accepted by the Treasury in December 2006, defined a
new framework for the funding of health research in the
UK [5-7]. Among other things, the report recommended
devoting a greater share of funding to 'translational'
research and the establishment of a board for transla-
tional medicine under the auspices of the new cross-cut-
ting Office for Strategic Coordination of Health Research
(OSCHR).
The report describes a 'pathway for translation of health
research into healthcare improvement' and identifies two
principal gaps in that pathway: 'the translation of basic
and clinical research into ideas and products', and 'intro-
ducing those ideas and products into clinical practice'
(Figure 1). Bridging the first gap (sometimes labelled as
T1) [1] involves preclinical development and early clinical
trials, whereas bridging the second (T2) involves health
technology assessment, health services research and
knowledge management [5]. Like the influential 'road-
map' developed by the National Institutes of Health
(NIH) in the United States [8], the pathway described is
clearly based on the process of drug development, whose
aims are to turn the findings of 'basic science' into a new
drug and to incorporate the use of the new drug into rou-
tine clinical practice for the benefit of individual patients
[9,10].
Towards a translational framework for public health 
research
Stakeholders and commentators have generally supported
Cooksey's recommendation to increase investment in
translational research. However, it is unclear whether the
linear, basic-to-applied, 'translational medicine' para-
digm is applicable to public health (or, indeed, to some
other related fields such as health care policy). In the case
of obesity, for example, despite the volume of relevant
basic science in genetics, physiology, pharmacology and
the behavioural sciences, the obvious translational out-
puts from this research – such as weight-loss drugs, or
campaigns to persuade the population to eat less and exer-
cise more – have not reversed the rising trend in the prev-
alence of obesity in the general population and appear
unlikely to do so [11,12]. The principle that public health
research is important and needs to be translated does not
appear to be in dispute. However, two critical questions
require to be addressed: what constitutes the public health
research to be translated, and how might that translation
be carried out effectively? Recent critiques of the NIH
roadmap have begun to address this problem, but have
Pathway for translation of health research into healthcare improvementFigure 1
Pathway for translation of health research into healthcare improvement. Source: A review of UK health research fund-
ing (the Cooksey report) [5]. © Crown copyright 2006. Reproduced with permission.
Blue boxes below parts of pathway correspond to specific responsibilities of public sector bodies supporting research. MRC: 
Medical Research Council. NHS R&D: National Health Service Research and Development. NHS HTA: NHS Health Technol-
ogy Assessment Programme. NHS SDO: Service and Delivery Organisation research programme. NHS CfH: Connecting for 
Health. 
Light blue boxes below parts of pathway correspond to the specific responsibilites of statutory regulatory agencies. MHRA: 
Medicines and Healthcare products Regulatory Agency. NICE: National Institute for Health and Clinical Excellence. Page 2 of 10
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improve clinical practice [8,13].
We aimed to develop a translational framework for public
health research to help define and inform future work in
this field. Our aim was to map the territory, the 'big pic-
ture' to which public health research should relate, rather
than to prescribe a particular route to be followed. We
intended to encompass both the 'iterative, bidirectional
circuitry of scientific discovery' [14] by which public
health research and public health action may influence
each other, and the research that may underpin, inform or
illuminate these interactions. We derived the framework
in a series of logical steps starting from the translational
pathway described in the Cooksey report [5], aiming to
balance a desire for a simple (intelligible) model with the
need to reflect the complexity of the public health envi-
ronment. We drew on the definitions of public health and
public health sciences used in the Acheson and Frankel
reports respectively and the circular model of 'diabetes
translation' described by Narayan and colleagues (Table
1) [15-18].
The framework is shown in Figure 2 and its key features
are summarised in Table 2. Four case studies (Table 3,
Table 4, Table 5 and Table 6) illustrate the limitations of
the linear translational medicine pathway and the impor-
tance of considering this wider framework.
Discussion
Characteristics of the framework
Our framework departs from the linear translational med-
icine pathway described by Cooksey in several important
ways.
An epidemiological perspective on the process and the endpoint
In contrast to the laboratory sciences that underpin trans-
lational medicine, epidemiology is the discipline that has
traditionally been considered the core basic science for
public health. In the classical epidemiological paradigm,
descriptive (hypothesis-generating) studies lead to analyt-
ical (hypothesis-testing) studies based on cohort and case-
control designs that identify putative risk factors for dis-
ease. Where strong evidence can be found for a causal rela-
tionship (e.g. according to the viewpoints enumerated by
Bradford Hill such as the importance of temporal, dose-
response and reversible associations) [19], these risk fac-
tors inform the selection, development and evaluation of
putative interventions to influence those risk factors –
either directly, or by targeting determinants of individuals'
health-related behaviour that may in turn influence those
risk factors (Table 3) [20,21].
The translational medicine pathway assumes that the
desired endpoint is the incorporation of an intervention
that has been declared effective into routine clinical prac-
tice [14]. However, the Acheson definition sees the objec-
tives of public health in much wider terms. Changes in
practice may well be necessary, but cannot possibly be
considered sufficient as an endpoint for public health pur-
poses. Our framework therefore redefines the endpoint as
population health improvement, whether ascertained as
changes in health-related behaviour or other risk factors
(in the shorter term), wellbeing or quality of life, or 'hard'
morbidity or mortality endpoints (in the longer term).
This implies a need for a feedback loop whereby popula-
tion health surveillance data contribute to the descriptive
epidemiology of the conditions under surveillance and
their risk factors (Table 4) [22-25]. It also acts as a coun-
terweight to a clinically-oriented understanding of public
health that sees public health practice as mainly con-
cerned with optimising health care rather than with pri-
mary or primordial prevention [17,18].
A social perspective on the basic sciences of public health
Most epidemiological research reflects an individual-level
perspective on health and its determinants. In contrast,
our framework reflects a spectrum of determinants of
health from modifiable risk factors (at the individual
level) to the social determinants of health (at the collec-
tive level). Logically, it also embraces a corresponding
spectrum of levels of intervention and of relevant 'under-
pinning' or 'basic' sciences [1,16], extending from the bio-
logical subspecialties of epidemiology through social and
Table 1: Starting points: selected definitions
Construct Definition
Public health 'the science and art of preventing disease, prolonging life, and promoting health through organized efforts of society' 
(Acheson report, 1998) [15]
Public health sciences 'Effective public health actions are based on scientifically derived information about factors influencing health and disease 
and about effective interventions to change behaviour at the level of the individual, the family, the community or wider 
society [...] The public health sciences are essential to further our understanding of the relative importance of 
environmental, lifestyle and genetic causes of disease[,] to identify strategies to improve the wellbeing of the population 
and to evaluate their impact' (Frankel report, 2004) [16]
Translational research 'comprehensive applied research that strives to translate the available knowledge and make it useful...' (Narayan et al, 2000) 
[17]Page 3 of 10
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– widely defined to include such fields as psychology,
sociology, anthropology and economics, thereby provid-
ing a range of insights into the determinants of both indi-
vidual and collective behaviour – and the environmental
sciences (Table 5) [26-31].
The Centers for Disease Control and Prevention have
defined translational research in public health as being
concerned with institutionalising 'proven', 'evidence-
based public health interventions' [32]. Our framework
recognises that it is unrealistic always to expect or require
unequivocal evidence of effectiveness of this kind – such
as might be required for the introduction of new drugs –
before recommending or advocating action to improve or
safeguard public health (Table 4) [33]. While it is clearly
essential to gather high-quality evidence about the effects
of interventions, the recent Foresight project on obesity
has illustrated how other types of evidence may influence
public health action, for example by demonstrating
adverse trends in health-related behaviour or by identify-
ing environmental correlates of behaviour that could
form the basis for interventions (Table 6) [34,35]. Inter-
vention studies can also contribute crucial knowledge
other than that derived from efficacy or effectiveness data,
such as qualitative insights into participants' motivations
and experiences.
All three domains of public health research identified in
the Frankel report [16] – understanding causes, identify-
ing strategies and evaluating their impact – are repre-
sented at multiple, overlapping points in the framework.
If 'understanding causes' is taken to be synonymous with
'basic sciences', then the basic sciences of public health are
Translational framework for public health researchFigure 2
Translational framework for public health research.Page 4 of 10
(page number not for citation purposes)
BMC Public Health 2009, 9:116 http://www.biomedcentral.com/1471-2458/9/116seen to have roles all over the framework – for example in
understanding the influence of the media on behaviour or
on policymaking, or in developing and validating instru-
ments for use in population health surveillance – and not
merely in providing the 'evidence' that is to be imple-
mented. 'Policy' is seen as both another class of interven-
tions whose impact on the population require to be
examined, and another class of causes whose influences
on health-related behaviour require to be examined by
these basic sciences (Table 3) [36].
An expanded role for evidence synthesis
Our framework identifies a pivotal role for evidence syn-
thesis – albeit of a more inclusive nature than is necessar-
ily typical of most current systematic reviews, which are
often exclusively concerned with evidence of efficacy or
effectiveness. At the same time, it acknowledges that iso-
lated research findings or even 'factoids' (assertions
repeated so frequently that they are assumed to be true)
influence policy and practice, whether helpfully or
unhelpfully (Table 5) [37-40]. This reflects an unresolved
tension between the apparently uncontentious principle
that the findings of single research studies should be dis-
seminated to groups of key policymakers and practition-
ers and an alternative view that it may be inappropriate or
even harmful to do so without placing those findings in
the context of all other available findings on the same
question [39,41,42] – a view reflected in the CONSORT
statement on the reporting of randomised controlled tri-
als [43].
It is increasingly argued – and often obvious – that evi-
dence synthesis which embraces inputs from the wider
range of disciplines and study designs outlined under the
'social perspective' above may be unlikely to produce
hard-edged findings that can easily be translated into
hard-edged recommendations for practice in terms of
'what works' [44,45]. To the more subtle contextual ques-
tions that are often important to decision-makers [46] –
such as those posed by realist evaluation: 'What works, for
whom, in what circumstances?' [47] – we might add that
evidence synthesis may produce pointers to unintended
Table 2: Key differences between the translational framework for public health research and the linear translational medicine 
pathway
Characteristics of the translational framework for public health research
Redefines the endpoint from that of institutionalising effective interventions to that of improving population health
Incorporates the epidemiological traditions of population health surveillance and the identification of modifiable risk factors
Reflects a spectrum of determinants of health from the individual to the collective level and a corresponding spectrum of levels of intervention
Embraces a wide range of biomedical, social and environmental 'basic sciences' that have roles throughout the framework, not merely in supplying 
knowledge to be implemented
Identifies a pivotal role for thoughtful and inclusive evidence synthesis
Describes the iterative and bidirectional processes by which public health research and public health action may influence each other
Recognises the non-linear and intersectoral interfaces with the public realm where decisions that influence population health are made
Table 3: Dietary salt and blood pressure
Case study
A dose-response relationship between dietary salt intake and blood pressure has been consistently demonstrated in animal studies and in 
ecological, cohort and intervention studies in humans. A recent randomised controlled trial has also shown that dietary and behavioural counselling 
to limit salt intake reduces the incidence of 'hard' cardiovascular endpoints, thus surely fulfilling any reasonable definition of an evidence-based 
public health intervention. The linear model of translation suggests that all that remains is for 'sodium reduction interventions' of this kind to be 
implemented as widely as possible [20,21].
However, an estimated 80% of dietary salt intake in Westernised countries comes from bread and processed foods rather than from discretionary 
use. Even if it were feasible to roll out intensive counselling across the population, shifting the population distribution of salt intake is therefore 
more likely to depend on changing the composition of processed foods. The greatest potential for translation into population health improvement 
may therefore lie not in disseminating and implementing a 'proven' intervention but in using other, predominantly epidemiological evidence to 
influence policymakers and the non-statutory corporate social responsibilities of food manufacturers. It may not be possible to demonstrate the 
population-level effectiveness (or otherwise) of regulatory interventions on food labelling or the salt content of processed foods until policymakers, 
somewhere, decide to intervene in this way as a 'natural experiment'; the effects could then be evaluated through enhanced population dietary and 
health surveillance [36].Page 5 of 10
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nuanced nature of these outputs suggests a need for a
feedback loop from the findings of evidence synthesis that
triggers the refinement of intervention strategies and
intervention hypotheses and their retesting using the most
appropriate study designs [49]. It also raises questions
about how the findings might be translated into practice
(Table 6).
A non-linear interface with the real world
The implied linear, rational way in which new knowledge
is converted into practice in the translational medicine
pathway has limited empirical support or practical utility
[14,50,51] and in any case, the practice that requires to be
influenced is not limited to clinical practice or even public
health practice. The targets for change in, for example, atti-
tudes and behaviour may include practitioners working in
other sectors (e.g. planners, architects, teachers and cater-
ers), civil servants, industry, politicians, and opinion and
culture in the population at large, for example through the
media (Table 3, Table 5 and Table 6). We have labelled
these wider targets for influence as the 'public realm' – a
realm in which opinion-formers and decision-makers are
unlikely to wait until researchers have satisfied themselves
as to what constitute 'evidence-based public health inter-
ventions' [24]. On the contrary, our framework reflects an
understanding that they may be influenced by more com-
plex and non-linear pathways such as that described in the
'enlightenment' or 'limestone' model of the gradual sedi-
mentation of ideas in the minds of research users [52] –
an example of the 'indirect insinuation' of evidence into
policy [53,54].
Moreover, interventions are rarely developed and intro-
duced only as a result of public health (or any other)
research. Many interventions that may influence health
are introduced for other reasons. These include: a per-
ceived political need to 'do something' in the absence of
strong scientific evidence that the chosen response is
likely to be effective [55] – possibly as a reaction to sur-
veillance data, to a 'factoid' [40], or to more robust but
'non-causal' evidence about correlates of behaviour; the
application of the precautionary approach; or to address
goals in another sector such as those of transport, environ-
Table 4: Sleeping position and sudden infant death syndrome
Case study
'Back to Sleep' campaigns to discourage the prone sleeping position are credited with having reduced the incidence of sudden infant death 
syndrome (SIDS) by 50–70%. The success of these campaigns reflects the effective translation of the findings of research in pathology and 
epidemiology into a comparatively simple intervention that was then effectively disseminated to health care professionals and parents.
However, the linear translational medicine pathway neither accounts for this success nor offers an obvious route to further reducing the impact of 
SIDS on the population. The case for 'Back to Sleep' was based not on clinical trials showing that the proposed intervention was effective, but on 
epidemiological evidence that the prone sleeping position was a risk factor for SIDS. The value of synthesising non-trial evidence is illustrated by the 
retrospective finding that this association could have been established by a meta-analysis of case-control studies as early as 1970, whereas many 
textbooks continued to recommend the prone sleeping position until the late 1980s. It has only been possible to demonstrate the effectiveness of 
the intervention after its widespread introduction and by using observational study designs. Meanwhile, continuing surveillance and observational 
epidemiology highlight possible side-effects such as an increase in plagiocephaly and show that SIDS is increasingly associated with deprivation, 
suggesting a need for action elsewhere in the public realm to reduce the risk among babies born into poor families [22-25].
Table 5: Human papillomavirus vaccine for cervical cancer
Case study
Human papillomovirus (HPV) vaccine can be used to protect adolescent girls against cervical cancer. Current calls to introduce an immunisation 
programme reflect the cumulation of evidence from aetiological epidemiology, which has identified HPV as a necessary cause of most cervical 
cancers, and translational medicine, which has produced a vaccine and shown it to be safe and effective in randomised controlled trials. The linear 
model of translation suggests that all that remains is for an immunisation programme to be implemented in primary care.
However, the UK experience of other recent translational activities in this field illustrates how these may have queered the pitch for new vaccines. 
The findings of one single, small and unreplicated study [37] were interpreted as showing that the measles, mumps and rubella (MMR) vaccine may 
cause autism and were deliberately released into the public realm where they were amplified and disseminated by the mass media, resulting in a 
marked decrease in MMR coverage to a low of 79% in England in 2003 [26]. This unintentional translational process was much more effective in 
changing population health-related behaviour (vaccine uptake) than was the subsequent systematic synthesis of epidemiological evidence [27]. It also 
directly produced a change in professional practice (the introduction of single-vaccine clinics) without this ever being recommended in clinical 
guidelines. The successful translation of the potential offered by the HPV vaccine into actual population health improvement will therefore depend, 
among other things, on winning the argument in the public realm that the benefits of routine immunisation outweigh the harms, and in particular 
that it is appropriate to immunise girls against a sexually transmitted infection before they become sexually active. Meanwhile, parents' attitudes and 
reactions to information about vaccines remains an active area of research that could be described as 'basic science' – in the sense that it 
investigates the causes of health-related behaviour – but is also clearly crucial to the effective translation of future advances in this field [28-31].Page 6 of 10
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also reflects these other drivers that may lead to (or pre-
vent) the introduction of interventions and also, there-
fore, the opportunity to study their effects. It shows that
health policy is only a subset of the policy arena that may
be the target of the knowledge produced by public health
research and may give rise to interventions that influence
health (Table 6).
Implications for translational research
The framework suggests a considerable programme of
work to characterise and operationalise the elements of
the framework, populate them with evidence and trans-
late that evidence into population health improvement.
This amounts to a translational agenda for public health
research.
Descriptive
The first area of work would involve describing the vari-
ous elements and links and how they are related, for
example by identifying the critical interfaces, receptors
and processes for translation [52] and barriers to transla-
tion [56] at each link. It would also involve reviewing the
theoretical understanding of how the processes consid-
ered important at each link are supposed to work, as
exemplified by current work on the theoretical basis of
behaviour change in public health interventions [57].
Effectiveness
The second area of work would involve reviewing the evi-
dence as to which processes are effective in practice and
identifying what further research would contribute most
to the understanding and effectiveness of each link. An
extensive literature on knowledge translation has already
demonstrated the effectiveness of practices such as inter-
active engagement compared with disseminating materi-
als for passive consumption [58]. However, knowledge
translation in these terms forms only one element of our
framework; different literature, or new primary research,
may be required to identify effective strategies required
elsewhere in the framework. For example, how can public
opinion be influenced in support of a given intervention,
how can authors and journals ensure that intervention
studies are reported with sufficient detail about imple-
mentation to inform subsequent evidence synthesis [59],
or how can the results of evidence synthesis be effectively
translated into new, more useful intervention studies?
Operationalisation
The third area of work would involve characterising the
roles and processes by which the various elements and
links are (or could be) operationalised. Although the liter-
ature on knowledge translation supports the need for
credible intermediaries [58], the diversity of terms cur-
rently in circulation – such as 'research brokers', 'research
translators' and 'translational scientists' – illustrates the
need for operational clarity. This could be elaborated by
identifying the potential contributions of different disci-
plines such as epidemiology, economics and sociology,
for example by building on the illustrative 'transdiscipli-
nary/translation matrix' described by Sussman and col-
leagues [60]. It would also involve disaggregating
elements currently represented as somewhat abstract
'black boxes' in the framework. To give two examples, the
analysis of the spectrum of modifiable determinants of
health could be disaggregated into the analysis of the rela-
tionship between exposure and outcome (aetiological
epidemiology) and the analysis of the determinants of
exposure that could form the basis for interventions, and
the newly revised Medical Research Council (MRC)
framework for complex interventions provides an obvious
starting point for operationalising the development of a
spectrum of possible interventions from theory and mod-
elling through to long-term implementation [61,62].
Strategic
The fourth area of work would involve reflection and
debate on the evidence gathered to agree where research
Table 6: NICE guidance on physical activity and the environment
Case study
The National Institute for Health and Clinical Excellence (NICE) provides evidence-based guidance for clinical practice in the National Health 
Service (NHS) in England. Each piece of guidance is based on the systematic review of evidence for the effectiveness and cost-effectiveness of 
interventions and is subsequently translated into a set of implementation materials. In principle, the NICE process therefore fits neatly into the 
'health technology assessment' component of the linear translational medicine pathway.
However, NICE's remit was expanded in 2005 to include public health, and its recent guidance on physical activity and the environment illustrates 
the need for a more inclusive translational framework. Most intervention studies reviewed for this guidance were of comparatively low quality and 
few demonstrated unequivocal changes in physical activity. However, rather than conclude that the evidence was insufficient, the programme 
development group drew on other types of evidence admissible under NICE procedures – including evidence about environmental correlates of 
physical activity, and interdisciplinary expert consensus – to make constructive recommendations based on a more inclusive approach to evidence 
synthesis. Most recommendations were intended for recipients outside the NHS such as transport planners, who have not previously been the 
target of NICE guidance and are under no obligation to take account of it. The successful implementation of this guidance is therefore likely to 
depend more on the 'indirect insinuation' of the recommendations into the practice of those working outside the health sector, perhaps by 
articulating an additional, public health case for interventions primarily motivated by other aims such as reducing traffic [35].Page 7 of 10
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maximum translational impact. For example, Lavis has
argued that the 'natural unit' for research translation
should be 'actionable messages' arising from systematic
reviews, and that the effort of promoting research findings
to a given category of user should be concentrated on the
fraction of systematic reviews that have an actionable
message for that particular audience [63]. This suggests
that undertaking a priori to 'disseminate' the findings of a
particular piece of public health research in the public
domain (as opposed to making the findings visible to oth-
ers working within the overall translation framework)
might, in some cases, be inefficient or even harmful.
Implications for research funding
Our framework illustrates Cooksey's observation that
public health research cannot readily be classified as basic
or applied, and indeed goes further by showing how a
wide range of public health research may contribute to the
overall translational framework. Even where a given piece
of research does not, or should not, give rise to an 'action-
able message' for policymakers, practitioners or the gen-
eral public, it may nonetheless contribute a crucial piece
to the jigsaw by which the sum of public health research
is eventually translated into population health improve-
ment.
The first implication for research funders is that resources
for 'applied' or 'translational' public health research
should be deployed across the framework and not be
reserved for a subset of studies concerned with 'dissemina-
tion' or 'implementation' of 'evidence-based interven-
tions'. The second is that in systems for appraising the
quality of research, the translational significance or per-
formance of a given piece of research should be assessed
in terms that realistically reflect its position within the
framework: for some studies, an appropriate objective
may be simply to inform debate, whereas for others, it
may be to stimulate better or different research or to
improve the methods by which others achieve those
objectives [58].
Summary
Despite the ambitious aims of public health reflected in
the Acheson definition, the public health research com-
munity cannot expect simply to issue pronouncements
that are accepted without question and result in the trans-
formation of society [64]. The influential paradigm of
translational medicine provides a useful starting point for
considering the translation of public health research, but
does not adequately reflect the complex reality of the pub-
lic health environment. We have therefore outlined a
translational framework for public health research, identi-
fying some gaps in knowledge and practice and enumerat-
ing a research agenda to be pursued.
All types of public health evidence, 'from epidemiology to
evaluation', may contribute to the shaping of policy, prac-
tice and future research, particularly when combined
using thoughtful approaches to evidence synthesis. The
framework and case studies show that further research is
required to understand, populate and operationalise all
the elements in the framework. It is not simply a matter of
applying what we already know; the 'basic sciences' of
public health still have much to contribute throughout
the framework. At the same time, rigorous evaluative and
implementation research is increasingly required and
should not be regarded as inferior to the more traditional
public health sciences.
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